NCT00176293View on ClinicalTrials.gov

Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Prostate Cancer

Interventions

DRUG

dexamethasone

oral dexamethasone, 12mg BID on days 1, 2, 3, 4, \& 5 of each 28-day cycle

DRUG

doxorubicin

Doxorubicin 50mg/m\^2 I.V. on day 5

Trial Locations (1)

40536

University of Kentucky, Lexington

Sponsors

Collaborators (1)

Ortho Biotech, Inc.

All Listed Sponsors

collaborator

Ortho Biotech, Inc.

INDUSTRY

lead

University of Kentucky

OTHER